Non-survivor, N = 53 | Survivor, N = 67 | p overall | |
---|---|---|---|
Age 65 | 0.248 | ||
< 65 | 37 (69.8%) | 54 (80.6%) | |
> 65 | 16 (30.2%) | 13 (19.4%) | |
Sex | 1.000 | ||
F | 10 (18.9%) | 12 (17.9%) | |
M | 43 (81.1%) | 55 (82.1%) | |
AFP (ng/ml) | 36.1 [5.40; 234] | 6.20 [3.50; 26.5] | < 0.001 |
Waiting_time (days) | 236 [77.0; 370] | 198 [64.5; 316] | 0.319 |
D (mm) | 36.8 (20.1) | 30.3 (21.1) | 0.091 |
MELD | 0.703 | ||
MELD ≤ 15 | 29 (69.0%) | 42 (76.4%) | |
MELD = 15–30 | 9 (21.4%) | 8 (14.5%) | |
MELD > 30 | 4 (9.52%) | 5 (9.09%) | |
preTreat | 0.319 | ||
No pre-treatment | 23 (43.4%) | 22 (32.8%) | |
Pre-treatment | 30 (56.6%) | 45 (67.2%) | |
N | 0.109 | ||
N = 1 | 18 (48.6%) | 41 (65.1%) | |
N = 1–3 | 12 (32.4%) | 18 (28.6%) | |
N > 3 | 7 (18.9%) | 4 (6.35%) | |
Grade | 0.559 | ||
1 | 8 (32.0%) | 15 (44.1%) | |
2 | 15 (60.0%) | 18 (52.9%) | |
3 | 2 (8.00%) | 1 (2.94%) | |
Asan | < 0.001 | ||
Exceeding | 25 (47.2%) | 10 (14.9%) | |
Fulfilling | 28 (52.8%) | 57 (85.1%) | |
AFP score | 0.002 | ||
> 2 | 18 (40.9%) | 8 (13.1%) | |
≤ 2 | 26 (59.1%) | 53 (86.9%) | |
MC | 0.001 | ||
Exceeding | 30 (56.6%) | 16 (23.9%) | |
Fulfilling | 23 (43.4%) | 51 (76.1%) | |
UTS | < 0.001 | ||
Exceeding | 26 (49.1%) | 8 (11.9%) | |
Fulfilling | 27 (50.9%) | 59 (88.1%) |